SAMSUNG BIOLOGICS CO.,LTD.
삼성바이오로직스(주)
207940CEO: 임존종보 (Rim John Chongbo)KOSPI
26.2Q Preliminary Results
PreliminaryRevenue
₩1.3T
QoQ +5.1%YoY +30.2%
Operating Profit
₩586.4B
QoQ +1.0%YoY +22.9%
Pre-tax Income
₩584.6B
QoQ -8.7%YoY +32.2%
Net Income
₩430.7B
QoQ -8.2%YoY +29.1%
Net Income (Owners)
₩430.7B
QoQ -8.2%YoY +29.1%
Disclosed 2026-07-23 · Preliminary figures may differ from final results
1,514,000KRW
+23,000 (+1.54%)
Open
1,487,000
High
1,514,000
Low
1,476,000
Volume
6만
PER
49.19
PBR
8.84
Insider Trading
BuySell
6월
7월
9월
11월
12월
5월
AI Financial Analysis
Check AI financial analysis in the app
AI comprehensively evaluates profitability, stability, growth, and more
Loading chart...
Data source: Korea FSS DART (Electronic Disclosure System)